US Stock MarketDetailed Quotes

PLUR Pluri Inc

Watchlist
  • 5.2500
  • +0.2000+3.96%
Close Apr 19 16:00 ET
  • 5.2800
  • +0.0300+0.57%
Post 18:09 ET
27.22MMarket Cap-1131P/E (TTM)

About Pluri Inc Company

Pluri, Inc. is a clinical stage company, which engages in cell therapy development. It develops placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory, and hematologic conditions. The firm focuses on the research, development, and manufacturing of cell-based products and technologies. Its products include Clinical Pipeline, PLX-Immune, PLX-PAD, and PLX-R18. The company was founded by Doron Shorrer on May 11, 2001 and is headquartered in Haifa, Israel.

Company Profile

SymbolPLUR
Company NamePluri Inc
Listing DateDec 10, 2007
Founded2001
CEOMr. Yaky Yanay
MarketNASDAQ
Employees134
Securities TypeOrdinary Shares
Fiscal Year Ends06-30
AddressMATAM Advanced Technology Park,Building No. 5
CityHaifa
ProvinceHaifa
CountryIsrael
Zip Code3508409
Phone972-74-710-8600
Websitehttps://pluri-biotech.com/

Company Executives

  • Name
  • Position
  • Salary
  • Yaky Yanay
  • Director, President and Chief Executive Officer
  • 1.30M
  • Chen Franco-Yehuda
  • Director, Chief Financial Officer, Principal Accounting Officer, Treasurer and Secretary
  • 608.21K
  • Zami Aberman
  • Chairman of the Board
  • 1.18M
  • Lorne Kenneth Abony
  • Director
  • --
  • Rami Levi
  • Independent Director
  • --
  • Doron Birger
  • Independent Director
  • 109.46K
  • Maital Shemesh-Rasmussen
  • Independent Director
  • 38.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg